| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |